[go: up one dir, main page]

ES531978A0 - Un procedimiento para preparar composiciones farmaceuticas de disolucion rapida que contienen como ingrediente activo triamteremo o metolazona. - Google Patents

Un procedimiento para preparar composiciones farmaceuticas de disolucion rapida que contienen como ingrediente activo triamteremo o metolazona.

Info

Publication number
ES531978A0
ES531978A0 ES531978A ES531978A ES531978A0 ES 531978 A0 ES531978 A0 ES 531978A0 ES 531978 A ES531978 A ES 531978A ES 531978 A ES531978 A ES 531978A ES 531978 A0 ES531978 A0 ES 531978A0
Authority
ES
Spain
Prior art keywords
triamteremo
metolazone
procedure
active ingredient
pharmaceutical compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES531978A
Other languages
English (en)
Other versions
ES8602418A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pennwalt Corp
Original Assignee
Pennwalt Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pennwalt Corp filed Critical Pennwalt Corp
Publication of ES531978A0 publication Critical patent/ES531978A0/es
Publication of ES8602418A1 publication Critical patent/ES8602418A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
ES531978A 1983-04-29 1984-04-27 Un procedimiento para preparar composiciones farmaceuticas de disolucion rapida que contienen como ingrediente activo triamteremo o metolazona. Expired ES8602418A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US49005683A 1983-04-29 1983-04-29
US06/586,605 US4517179A (en) 1983-04-29 1984-03-06 Rapid dissolving, uniform drug compositions and their preparation

Publications (2)

Publication Number Publication Date
ES531978A0 true ES531978A0 (es) 1985-12-01
ES8602418A1 ES8602418A1 (es) 1985-12-01

Family

ID=27049920

Family Applications (1)

Application Number Title Priority Date Filing Date
ES531978A Expired ES8602418A1 (es) 1983-04-29 1984-04-27 Un procedimiento para preparar composiciones farmaceuticas de disolucion rapida que contienen como ingrediente activo triamteremo o metolazona.

Country Status (13)

Country Link
US (1) US4517179A (es)
EP (1) EP0124027B1 (es)
AU (1) AU565640B2 (es)
CA (1) CA1216236A (es)
CH (1) CH662947A5 (es)
DE (1) DE3482402D1 (es)
DK (1) DK162630C (es)
ES (1) ES8602418A1 (es)
FI (1) FI85215C (es)
IE (1) IE57137B1 (es)
IL (1) IL71506A (es)
NZ (1) NZ207678A (es)
PT (1) PT78395B (es)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4721709A (en) * 1984-07-26 1988-01-26 Pyare Seth Novel pharmaceutical compositions containing hydrophobic practically water-insoluble drugs adsorbed on pharmaceutical excipients as carrier; process for their preparation and the use of said compositions
US4639458A (en) * 1985-01-22 1987-01-27 Merck & Co., Inc. Tablet and formulation
US4851392A (en) * 1985-02-05 1989-07-25 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US4818539A (en) * 1985-02-05 1989-04-04 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US4747881A (en) * 1985-02-05 1988-05-31 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US4843098A (en) * 1985-02-05 1989-06-27 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US4790991A (en) * 1985-02-05 1988-12-13 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US4684534A (en) * 1985-02-19 1987-08-04 Dynagram Corporation Of America Quick-liquifying, chewable tablet
US5028633A (en) * 1985-02-21 1991-07-02 Freund Industrial Co., Ltd. Excipient for use in compression molding and process of preparation
US4744987A (en) * 1985-03-08 1988-05-17 Fmc Corporation Coprocessed microcrystalline cellulose and calcium carbonate composition and its preparation
US4707361A (en) * 1985-08-02 1987-11-17 Stauffer Chemical Company Granular anhydrous dicalcium phosphate compositions suitable for direct compression tableting
GB8524001D0 (en) * 1985-09-30 1985-11-06 Glaxo Group Ltd Pharmaceutical composition
US4677130A (en) * 1985-10-07 1987-06-30 Great Lakes Chemical Corporation Process of densification of N-halohydantoin compositions and products thereof
EP0418597A3 (en) * 1989-09-21 1991-11-27 American Cyanamid Company Controlled release carbonic anhydrase inhibitor containing pharmaceutical compositions from spherical granules in capsule oral dosage unit form
HU206824B (en) * 1990-08-24 1993-01-28 Biogal Gyogyszergyar Process for the production of a table crystallizing in the monoclinic system, which contains light-, heat-, and moisture- sensitive active agents
US5643591A (en) * 1991-01-16 1997-07-01 Fmc Corporation Solid dosage forms
US5629016A (en) * 1991-01-30 1997-05-13 Glaxo Wellcome Inc. Water-dispersible tablets
IE77165B1 (en) * 1991-01-30 1997-12-03 Wellcome Found Water-dispersible tablet containing acyclovir
EP0587744B1 (en) * 1991-05-28 2003-07-16 McNEIL-PPC, Inc. Chewable drug-delivery composition
GB9215908D0 (en) * 1992-07-27 1992-09-09 Wellcome Found Water dispersible tablets
CZ287984B6 (cs) * 1993-05-15 2001-03-14 Roche Diagnostics Gmbh Tableta se zlepšenou biodostupností účinné látky, kyseliny klodronové, a způsob její výroby
US5698226A (en) * 1993-07-13 1997-12-16 Glaxo Wellcome Inc. Water-dispersible tablets
DE69520292T2 (de) * 1994-12-14 2001-06-13 Bioglan Ireland (R & D) Ltd., Dublin Pharmazeutische zubereitung zur direktverpressung
DE19530575A1 (de) * 1995-08-19 1997-02-20 Gruenenthal Gmbh Schnell zerfallende Arzneiform von Tramadol oder einem Tramadolsalz
US5807577A (en) * 1995-11-22 1998-09-15 Lab Pharmaceutical Research International Inc. Fast-melt tablet and method of making same
US5807578A (en) * 1995-11-22 1998-09-15 Lab Pharmaceutical Research International Inc. Fast-melt tablet and method of making same
US6037380A (en) * 1997-04-11 2000-03-14 Fmc Corporation Ultra-fine microcrystalline cellulose compositions and process
AR017512A1 (es) * 1997-08-22 2001-09-12 Smithkline Beecham Corp Tabletas de metilcelulosa rapidamente desintegrables para administracion por via oral y procedimiento para prepararlas
AR016827A1 (es) 1997-08-22 2001-08-01 Smithkline Beecham Corp PROCEDIMIENTO PARA LA PREPARACIoN DE UNA TABLETA FARMACÉUTICA
SE9802973D0 (sv) * 1998-09-03 1998-09-03 Astra Ab Immediate release tablet
US7815937B2 (en) * 1998-10-27 2010-10-19 Biovail Laboratories International Srl Quick dissolve compositions and tablets based thereon
AU1323400A (en) * 1998-10-27 2000-05-15 Fuisz Technologies Ltd. Microparticles containing peg and/or peg glyceryl esters
US6552024B1 (en) 1999-01-21 2003-04-22 Lavipharm Laboratories Inc. Compositions and methods for mucosal delivery
US6048874A (en) * 1999-01-26 2000-04-11 Medeva Pharmaceuticals Manufacturing, Inc. Parenteral metolazone formulations
GEP20053427B (en) 1999-12-23 2005-01-25 Pfizer Prod Inc Pharmaceutical Compositions Providing Enhanced Drug Concentrations
US6602523B1 (en) 2000-08-17 2003-08-05 Technology Holding, Llc. Composite material and process for increasing bioavailability and activity of a beneficial agent
US6462022B1 (en) * 2001-09-24 2002-10-08 Astrazeneca Ab Lisinopril compositions having large-particle DCPD
US20040048931A1 (en) * 2002-07-12 2004-03-11 Craig Heacock Modafinil pharmaceutical compositions
AU2003304236A1 (en) * 2002-08-30 2005-01-13 Pharmacia Corporation Pharmaceutical solid dosage forms exhibiting reproductible drug release profile
US20040265375A1 (en) * 2003-04-16 2004-12-30 Platteeuw Johannes J. Orally disintegrating tablets
US20040253308A1 (en) * 2003-04-29 2004-12-16 Barr Laboratories, Inc. Surface-treated modafinil particles
US20080146592A1 (en) * 2003-07-31 2008-06-19 Puschett Jules B Method of Treating Preeclampsia Employing Metolazone
ES2737348T3 (es) 2003-09-12 2020-01-13 Amgen Inc Formulación de disolución rápida que comprende cinacalcet HCl
US7344907B2 (en) * 2004-11-19 2008-03-18 International Business Machines Corporation Apparatus and methods for encapsulating microelectromechanical (MEM) devices on a wafer scale
CA2687124A1 (en) * 2006-05-19 2007-12-13 Somaxon Pharmaceuticals, Inc. Low dose doxepin formulations, including buccal, sublingual and fastmelt formulations, and uses of the same to treat insomnia
US20080058408A1 (en) 2006-05-19 2008-03-06 Rogowski Roberta L Low-dose doxepin for treatment of sleep disorders in elderly patients
US20080181966A1 (en) * 2006-10-18 2008-07-31 Cephalon, Inc. Modafinil pharmaceutical compositions
US20080145423A1 (en) * 2006-12-14 2008-06-19 Ajmal Ali Khan Chewable tablet and method of formulating
EP1977734A1 (en) * 2007-04-03 2008-10-08 Royal College of Surgeons in Ireland A method of producing fast dissolving tablets
CA2721133C (en) 2007-04-13 2018-11-06 Somaxon Pharmaceuticals, Inc. Low-dose doxepin formulations and methods of making and using the same
WO2009123580A1 (en) * 2008-04-01 2009-10-08 Schering-Plough Healthcare Products, Inc. Chewable tablet and method of formulating
TWI461213B (zh) 2009-11-05 2014-11-21 Fmc Corp 作為藥物賦形劑之微晶纖維素及磷酸鈣之組合物
US11052049B2 (en) * 2019-04-11 2021-07-06 Atoz Pharmaceuticals Pvt Ltd Capsule dosage forms of triamterene, and process of preparation thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3134719A (en) * 1962-04-05 1964-05-26 American Cyanamid Co Calcium phosphates in tablet compressing
US3360518A (en) * 1966-01-03 1967-12-26 Wallace & Tiernan Inc Tetrahydro-halo-sulfamyl quinazolinones
NL6701470A (es) * 1966-02-03 1967-08-04
US3745216A (en) * 1969-12-18 1973-07-10 Smith Kline French Lab Compositions and methods for producing hypotensive activity with imidazo and pyrimido(2,1-b)quinazoline compounds
DE2416903A1 (de) * 1974-04-06 1975-10-09 Bayer Ag Verwendung von schmelzverspruehtem kugelfoermigem phenacetingranulat zur herstellung von tabletten im direkttablettierverfahren
DE2658500C2 (de) * 1976-12-23 1986-10-09 Knoll Ag, 6700 Ludwigshafen Pharmazeutische Präparate mit kardioprotektiver Wirkung
WO1981002521A1 (en) * 1980-03-10 1981-09-17 Mendell Co Inc Edward Pharmaceutical vehicle composition and process of producing same
DE3012862A1 (de) * 1980-04-02 1981-10-08 Cassella Ag, 6000 Frankfurt Substituierte 1,2,5-oxdiazol-2-oxide als pharmazeutische wirkstoffe, ihre verwendung und sie enthaltende arzneimittel
DE3107933A1 (de) * 1981-03-02 1982-09-16 Cassella Ag, 6000 Frankfurt Substituierte 3-amino-sydnonimine, verfahren zu ihrer herstellung und ihre verwendung

Also Published As

Publication number Publication date
AU2643484A (en) 1984-11-01
DK211084D0 (da) 1984-04-27
US4517179A (en) 1985-05-14
EP0124027A1 (en) 1984-11-07
FI85215C (fi) 1992-03-25
EP0124027B1 (en) 1990-06-06
IE840735L (en) 1984-10-29
CA1216236A (en) 1987-01-06
PT78395A (en) 1984-05-01
DK162630B (da) 1991-11-25
DK162630C (da) 1992-04-13
AU565640B2 (en) 1987-09-24
DK211084A (da) 1984-10-30
CH662947A5 (de) 1987-11-13
FI85215B (fi) 1991-12-13
FI841696L (fi) 1984-10-30
ES8602418A1 (es) 1985-12-01
IL71506A (en) 1987-09-16
NZ207678A (en) 1986-11-12
DE3482402D1 (de) 1990-07-12
IL71506A0 (en) 1984-07-31
PT78395B (en) 1986-06-02
FI841696A0 (fi) 1984-04-27
IE57137B1 (en) 1992-05-06

Similar Documents

Publication Publication Date Title
ES531978A0 (es) Un procedimiento para preparar composiciones farmaceuticas de disolucion rapida que contienen como ingrediente activo triamteremo o metolazona.
ES513181A0 (es) "un procedimiento para preparar una composicion herbicida que contiene como ingrediente activo un derivado de acido hidroxamico".
IT8921118A0 (it) Composizione per aerosol comprendente nitroglicerina come ingrediente attivo.
MX9202407A (es) Composicion farmaceutica que contiene un compuesto de alilamina como el agente activo y proceso para su preparacion.
ES503011A0 (es) Un procedimiento para la preparacion de una formulacion por-tadora de farmacos,biodegradable y magneticamente localiza- ble
FI844799A7 (fi) Vaikutusaineen vapauttamisjärjestelmä.
AR240225A1 (es) Composicion insecticida que comprende mas de un compuesto activo.
ES522107A0 (es) Procedimiento para preparar composiciones farmaceuticas inyectadas que contienen derivados de 2-metil-3-carboxamida-4-hidroxitiazina 1,1-dioxido.
ATE1524T1 (de) Phenyl- oder phenoxy-substituierte spiroimidazolidindion-derivate, deren pharmazeutische zusammensetzungen und verfahren zu ihrer herstellung.
IT1190824B (it) Composizione farmaceutica contenente 24,25-diidrossicolecalciferolo come ingrediente attivo
AR240381A1 (es) Composicones protectoras de las plantas basadas en emulsiones acuosas que contienen una o mas substancias activas, y procedimiento para su preparacion.
DK398583A (da) Spergualin-beslaegtede forbindelser, fremgangsmaader til fremstilling deraf samt deres anvendelse som laegemidler
MX14253A (es) Compuestos de amonio cuaternario, composiciones farmaceuticas que incluyen los compuestos y procedimiento para preparar los compuestos de amonio cuaternario.
AR240450A1 (es) Excluida su aplicacion en o sobre animales, derivados de acido oxamidico, procedimiento para su preparacion y composiciones parasiticidas que los contienen.
FI843560A7 (fi) Mevalonolaktonin analogeja ja niiden johdannaisia, menetelmiä niiden valmistamiseksi, niitä sisältäviä farmaseuttisia yhdistelmiä ja niide n käyttö farmaseuttisina aineina.
ES525574A0 (es) Procedimiento para producir preparaciones farmaceuticas que contienen como substancias activas derivados de polialquilenglicol.
DK494684D0 (da) Benzensulfonyl-lactamer, fremgangsmaade til deres fremstilling og deres anvendelse som aktiv komponent i framaceutiske kompositioner
MX24039A (es) Composiciones farmaceuticas que contienen una calcitonina como principio activo.
FI873799A7 (fi) Aminoglykosidisteroideja, menetelmä niiden valmistamiseksi, niiden käy ttö sekä niitä sisältävät farmaseuttiset seokset.
AR240814A1 (es) Nuevos derivados de acilamino-s-triazina, procedimiento para su preparacion y composiciones antiparasitarias que los contienen, excluida su actividad terapeutica.
MX9100441A (es) Procedimiento para fabricar preparados solidos orales,que contienen ifosfamida como agente activo
FI831687A7 (fi) Farmaseuttisia seoksia, jotka sisältävät useampia aktiivisia aineosia.
DK586284D0 (da) Quinoloncarboxylsyre-derivater, fremgangsmaade til fremstilling deraf samt anvendelse af saadanne derivater som laegemiddel
DK209384D0 (da) 4-phenyl-tetrahydro-furano-pyridiner og syreadditionssalte deraf,fremgangsmaade til deres fremstilling og farmaceutiske kompositioner indeholdende forbindelserne
FI822671A7 (fi) Aminoglykosidijohdannaisia, menetelmiä niiden valmistamiseksi, niitä sisältäviä farmaseuttisia koostumuksia ssekä tällaisia johdannaisia kä ytettäviksi lääkeaineina.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970303